Clinical significance of variant hepatic artery in pancreatic resection: A comprehensive review

Table 3 Oncological outcomes of pancreaticoduodenectomy in patients with and without aberrant hepatic artery (> 50 cases)

Author	Total, n	AHA, n	R0 resection, n (%)		Median OS (mo)		Median HLN, n
			AHA	n-AHA	AHA	n-AHA	AHA	n-AHA
OPD
Crocetti et al[34]	297	441	42 (95.5)	220 (87.0)	30	25	NA	NA
Alexakis2 et al[4]	105	35	29 (82.9)	56 (80.0)	NA	NA	NA	NA
Rubio-Manzanares-Dorado et al[62]	151	11	11 (100.0)	116 (82.9)	NA	NA	10	12
Rammohan et al[17]	225	43	40 (93.1)	169 (92.9)	NA	NA	12	12
Kim et al[26]	249	371	33 (89.2)	178 (84.0)	17	23	17	17
Sulpice2 et al[30]	84	291	25 (86.2)	49 (89.1)	21.8	23.6	16	26
Turrini et al[29]	62	31	25 (80.7)	26 (83.9)	23	17	11	13
Lee et al[28]	103	151	12 (80.0)	66 (75.0)	29.8	28.7	NA	NA
LPD
Wang et al[7]	576	127	NA	NA	28	32	15	14
Giani et al[25]	72	141	11 (84.6)	50 (86.2)	NA	NA	223	173
Zhang et al[3]	218	54	54 (100.0)	163 (99.4)	NA	NA	18.59	18.26
RPD
Nguyen et al[31]	115	27	25 (92.6)	77 (87.5)	NA	NA	22.3	17.5

¹AHA in these studies included only right hepatic artery variants.

²These studies provided matched analysis.

³The P value for this comparison was 0.032, while all others were > 0.05.

AHA: Aberrant hepatic artery; HLN: Number of harvested lymph nodes; LPD: Laparoscopic pancreaticoduodenectomy; n-AHA: Non-aberrant hepatic artery; NA: Not available; OPD: Open pancreaticoduodenectomy; OS: Overall survival; RPD: Robotic pancreaticoduodenectomy.